ABSTRACT:Senecionine (SEN) is a representative of the hepatotoxic pyrrolizidine alkaloids. Although phase I metabolism for cytochrome P450-mediated metabolic activation of SEN was investigated extensively, phase II metabolism for glucuronidation of this compound has not been investigated until now. In our present study, one unique glucuronidation product of SEN in human liver microsomes (HLMs) was identified as SEN N-glucuronide using an authentically synthesized product for which the structure was identified via 1 H Hepatotoxic pyrrolizidine alkaloids (HPAs) are widely distributed in higher plants around the world (Roeder, 1995) and are highly toxic to wildlife (Hartmann, 2008), livestock (Nobre et al., 2005Stegelmeier et al., 2009), experimental animals (Tang et al., 2007, and humans (Stegelmeier et al., 1999) by multiple pathways such as consumption of foods (Crews et al., 1997;Prakash et al., 1999) and use of traditional herbs (Roeder, 1995(Roeder, , 2000 containing HPAs.In general, HPAs induce liver intoxication through metabolic activation by liver P450 enzymes, especially CYP3A4, to form reactive dehydrogenated pyrrolic esters (Couet et al., 1996) that can covalently conjugate with proteins and nucleic acids to evoke various toxicities such as cell necrosis, veno-occlusive diseases, and carcinogenicity (Fu et al., 2004). However, other detoxification pathways of HPAs were also observed, such as nonenzymatic dehydrogenated pyrrole-glutathione conjugation (Lin et al., 2000), N-oxidation (Huan et al., 1998) catalyzed by flavin-containing monooxygenase, and hydrolysis catalyzed by guinea pig hepatic carboxylesterase (Dueker et al., 1992).As the most important phase II drug-metabolizing enzymes, UDPglucuronosyl transferases (UGTs) play a very important role in the elimination of xenobiotic and endogenous substances and nearly half of the known phase II metabolism of the top 200 prescribed drugs in United States is catalyzed by them (Williams et al., 2004). However, whether UGTs participate in the metabolism of HPAs is still not clear.In our preliminary experiment, senecionine (SEN) (Fig. 1), a representative HPA isolated from Senecio vulgaris, underwent glucuronidation by UGTs in human liver microsomes (HLMs). As a competitive metabolic pathway of P450-mediated metabolic activation, glucuronidation is promising as a new detoxification pathway of SEN, and the UGT isozyme(s) participating in SEN glucuronidation needs to be clarified.The purpose of this study was to authenticate the conjugated site of SEN by glucuronic acid and to identify the UGT isozyme(s) partici-